ANTI STRESS valeriana (oral drops, solution for cats and kittens)

Brown liquid with a characteristic odour of the ingredients; slight sediment may occur.

1 ml of the product contains:

- phenibut — 100 mg.

Excipients: valerian root dry extract, mint dry extract, motherwort dry extract, hop cone dry extract, juniper dry extract, sodium benzoate, sucralose, glycerol, purified water.

ATCvet classification code: QN06BX Other veterinary medicinal products with psychostimulant and nootropic action. QN06BX22 phenibut.

Phenibut is a phenyl derivative of gamma-aminobutyric acid (GABA) and structurally related to phenylethylamine; it is chemically aminophenylbutyric acid hydrochloride. By enhancing inhibitory GABAergic processes, it improves the functional state by normalising metabolism and improving cerebral circulation, increasing blood flow velocity and reducing vascular tone. It has a pronounced anti-stress effect, normalising excitation and inhibition processes in the central nervous system. Phenibut is also used for the prevention of motion sickness (kinetosis).

The complex of herbal plant material extracts potentiates the sedative action of the product, helping to reduce excessive tension and fear, improving recovery and adaptive processes, and increasing resistance to adverse environmental factors.

With respect to its degree of influence on the body, the product  is classified as a low-hazard substance; at the recommended doses, it does not have mutagenic, carcinogenic or sensitising effects.

The product is used in cats to reduce excitation and correct psychogenic behavioural disorders in cases of stress, phobias, aggression without apparent cause, and increased sexual arousal (in combination with contraceptive agents).

The product is used to improve recovery and adaptive processes in animals and to increase resistance to adverse environmental factors.

It is also used for the prevention of kinetosis (motion sickness syndrome).

Administer orally to cats, either directly onto the root of the tongue, into the cheek pouch, or mixed with a small amount of a treat, taking into account the animal’s body weight, behavioural status and degree of excitation, at the following daily doses:

Cats (adult animals and kittens) — 1 drop (0,05 ml) of the product (equivalent to 5 mg of phenibut) per 1 kg of body weight.

The daily dose is divided into two administrations, given in the morning and in the evening.

The course of treatment is 15–20 days.

In cases of excessive excitation or psychogenic behavioural disorders (aggression, fear, hyperactivity, excessive vocalisation (barking, meowing), increased sexual activity, urine marking in the house), the course of treatment may be extended to 4 weeks.

In the event of recurrent behavioural disorders, the course of treatment is repeated at the same doses and according to the same schedule.

For stress prevention (transport, arrival of guests, change of environment, owner's absence, intensive training, participation in shows and competitions), the product is administered 3–5 days before the anticipated event and for 1–4 days after its completion.

For the prevention of motion sickness, administer once at the above-mentioned doses 1–2 hours before the anticipated start of animal transport. If pronounced signs of motion sickness are already present (vomiting), the product is of limited efficacy.

For behavioural correction in cases of increased sexual activity, the product is used at the same doses together with contraceptive agents. The duration of the treatment course depends on the individual sensitivity of the animal and its degree of excitation.

Individual hypersensitivity of the animal to the components of the product (including a history thereof).

Do not use in animals with urogenital disorders, neoplastic diseases or diabetes.

Do not use in pregnant or lactating females.

In rare cases, at the first administration, the animal may experience drowsiness or agitation, irritability, nausea, or allergic reactions. Administration of the product should be discontinued and symptomatic and desensitising therapy should be initiated.

When used concurrently with tranquillisers, antipsychotics, and anticonvulsants, the product potentiates and prolongs the effects of the latter.

In rare cases, individual animals may experience drowsiness or agitation, irritability, nausea, or allergic reactions. In such cases, administration of the product should be discontinued and symptomatic and desensitising therapy should be initiated. Recommended doses should be observed.

Polymer or glass bottles of 10 or 15 ml, packed in cardboard cartons with a dosing syringe.

Store in a dry, dark place, out of reach of children, at a temperature of 5 to 25 °C.

2 years.

After first opening of the bottle, the product must be used within 30 days, provided it is stored in a dark place at a temperature of 5 to 10 °C.